Cascadian Therapeutics, Inc. of SEATTLE, WA filed a DEF 14A with the SEC on 2009-04-30. Industry: Services-Commercial Physical & Biological Research.
| Seq | Type | Description |
|---|---|---|
| 1 | DEF 14A | DEFINITIVE PROXY STATEMENT |
| 2 | GRAPHIC | GRAPHIC |
| 3 | GRAPHIC | GRAPHIC |
| 4 | GRAPHIC | GRAPHIC |
| 5 | GRAPHIC | GRAPHIC |
| 6 | GRAPHIC | GRAPHIC |
Showing 12 of 41 filings.
| Filed | Form |
|---|---|
| 2018-03-09 | SC 14D9/A |
| 2018-02-26 | SC 14D9/A |
| 2018-02-16 | SC 14D9/A |
| 2018-02-14 | SC 14D9/A |
| 2018-02-08 | SC 14D9 |
| 2018-01-31 | SC14D9C |
| 2017-04-26 | DEFA14A |
| 2017-04-26 | DEF 14A |
| 2017-04-14 | PRE 14A |
| 2016-10-14 | DEF 14A |
| 2016-10-04 | DEFA14A |
| 2016-10-04 | PRE 14A |